Implications of the structure of human uridine phosphorylase 1 on the development of novel inhibitors for improving the therapeutic window of fluoropyrimidine chemotherapy

Roosild, Tarmo P.; Castronovo, Samantha; Fabbiani, Michael; Pizzorno, Giuseppe
January 2009
BMC Structural Biology;2009, Vol. 9, Special section p1
Academic Journal
Background: Uridine phosphorylase (UPP) is a key enzyme of pyrimidine salvage pathways, catalyzing the reversible phosphorolysis of ribosides of uracil to nucleobases and ribose 1-phosphate. It is also a critical enzyme in the activation of pyrimidine-based chemotherapeutic compounds such a 5-fluorouracil (5-FU) and its prodrug capecitabine. Additionally, an elevated level of this enzyme in certain tumours is believed to contribute to the selectivity of such drugs. However, the clinical effectiveness of these fluoropyrimidine antimetabolites is hampered by their toxicity to normal tissue. In response to this limitation, specific inhibitors of UPP, such as 5-benzylacyclouridine (BAU), have been developed and investigated for their ability to modulate the cytotoxic side effects of 5-FU and its derivatives, so as to increase the therapeutic index of these agents. Results: In this report we present the high resolution structures of human uridine phosphorylase 1 (hUPP1) in ligand-free and BAU-inhibited conformations. The structures confirm the unexpected solution observation that the human enzyme is dimeric in contrast to the hexameric assembly present in microbial UPPs. They also reveal in detail the mechanism by which BAU engages the active site of the protein and subsequently disables the enzyme by locking the protein in a closed conformation. The observed inter-domain motion of the dimeric human enzyme is much greater than that seen in previous UPP structures and may result from the simpler oligomeric organization. Conclusion: The structural details underlying hUPP1's active site and additional surfaces beyond these catalytic residues, which coordinate binding of BAU and other acyclouridine analogues, suggest avenues for future design of more potent inhibitors of this enzyme. Notably, the loop forming the back wall of the substrate binding pocket is conformationally different and substantially less flexible in hUPP1 than in previously studied microbial homologues. These distinctions can be utilized to discover novel inhibitory compounds specifically optimized for efficacy against the human enzyme as a step toward the development of more effective chemotherapeutic regimens that can selectively protect normal tissues with inherently lower UPP activity.


Related Articles

  • Chips off the old block. Mueller, Eugene G. // Nature Structural Biology;May2002, Vol. 9 Issue 5, p320 

    Reports that a lack of sequence similarity made it uncertain whether the four families of pseudouridine synthases arose by convergent or divergent evolution. Description on the pseudouridine synthases; Information on the structure of TruB; Background on the catalytic Asp.

  • Structure of the 16S rRNA pseudouridine synthase RsuA bound to uracil and UMP. Sivaraman, J.; Sauvé, Véronique; Larocque, Robert; Stura, Enrico A.; Schrag, Joseph D.; Cygler, Miroslaw; Matte, Allan // Nature Structural Biology;May2002, Vol. 9 Issue 5, p353 

    In Escherichia coli, the pseudouridine synthase RsuA catalyzes formation of pseudouridine (ψ) at position 516 in 16S rRNA during assembly of the 30S ribosomal subunit. We have determined the crystal structure of RsuA bound to uracil at 2.0 Å resolution and to uridine...

  • Structure of a functional ribonucleoprotein pseudouridine synthase bound to a substrate RNA. Bo Liang; Jing Zhou; Kahen, Elliot; Terns, Rebecca M.; Terns, Michael P.; Hong Li // Nature Structural & Molecular Biology;Jul2009, Vol. 16 Issue 7, p740 

    Box H/ACA small nucleolar and Cajal body ribonucleoprotein particles comprise the most complex pseudouridine synthases and are essential for ribosome and spliceosome maturation. The multistep and multicomponent-mediated enzyme mechanism remains only partially understood. Here we report a crystal...

  • H/ACA snoRNP CORE PARTICLES ARE SUFFICIENT FOR PSEUDOURIDYLATION OF RIBOSOMAL RNA IN VITRO. Wang, C.; Query, C.; Meier, U.T. // Einstein Quarterly: Journal of Biology & Medicine;2002, Vol. 19 Issue 4, p179 

    The biosynthesis of eukaryotic ribosome occurs in the nucleolus where the ribosomal RNA (rRNA) precursor is transcribed, processed, and extensively modified. One of the major modification, the isomerization of uridine to pseudouridine (pseudouridylation), is guided by a class of small nucleolar...

  • Hyaluronic acid production by recombinant Lactococcus lactis. Liang-Jung Chien; Cheng-Kang Lee // Applied Microbiology & Biotechnology;Nov2007, Vol. 77 Issue 2, p339 

    Microbial hyaluronic acid (HA), commonly produced by pathogenic Streptococcus, was made possible to be produced by a generally recognized as safe Lactococcus lactis by coexpressing HA synthase and uridine diphosphate–glucose dehydrogenase (UDP-GlcDH) of Streptococcus equi subsp....

  • Human uridine-cytidine kinase phosphorylation of ribavirin: a convenient method for activation of ribavirin for conjugation to proteins. Virovic Jukic, Lucija; Duvnjak, Marko; Wu, Catherine H.; Wu, George Y. // Journal of Biomedical Science;Mar2008, Vol. 15 Issue 2, p205 

    Ribavirin is a synthetic nucleoside analog that is used for the treatment of hepatitis C virus (HCV) infection. Its primary toxicity is hemolytic anemia, which sometimes necessitates dose reduction or discontinuation of therapy. Selective delivery of ribavirin into liver cells would be desirable...

  • The Human MYOD1 Transgene Is Suppressed by 5-Bromodeoxyuridine in Mouse Myoblasts1. Ogino, Hideki; Satou, Wataru; Fujii, Michihiko; Suzuki, Toshikazu; He, Yuan; Michishita, Eriko; Ayusawa, Dai // Journal of Biochemistry;2002, Vol. 132 Issue 6, p953 

    5-Bromodeoxyuridine (BrdU) immediately and clearly suppresses expression of the mouse Myod1 and human MYOD1 genes in myoblastic cells. Despite various studies, its molecular mechanism remains unknown. We failed to identify a BrdU-responsive element of the genes in experiments in which reporter...

  • Elements essential for accumulation and function of small nucleolar RNAs directing site-specific pseudouridylation of ribosomal RNAs. Bortolin, Marie-Line; Ganot, Philippe; Kiss, Tam�s // EMBO Journal;1/15/99, Vol. 18 Issue 2, p457 

    During site-specific pseudouridylation of eukaryotic rRNAs, selection of correct substrate uridines for isomerization into pseudouridine is directed by small nucleolar RNAs (snoRNAs). The pseudouridylation guide snoRNAs share a common �hairpin�hinge�hairpin�tail�...

  • RNAsnoop: efficient target prediction for H/ACA snoRNAs. Tafer, Hakim; Kehr, Stephanie; Hertel, Jana; Hofacker, Ivo L.; Stadler, Peter F. // Bioinformatics;Mar2010, Vol. 26 Issue 5, p610 

    Motivation: Small nucleolar RNAs are an abundant class of non-coding RNAs that guide chemical modifications of rRNAs, snRNAs and some mRNAs. In the case of many ‘orphan’ snoRNAs, the targeted nucleotides remain unknown, however. The box H/ACA subclass determines uridine residues...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics